Friday, Oct 31, 2025 · SEC filings
What the smart money revealed on Oct 31
228 insider filings came in. We hid 43 planned (10b5-1) sellers and 110 people whose filings were routine, like grants and tax withholding.
Amrize (AMRZ) Chairman & CEO Jan Jenisch bought $5.8M
110,000 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.
Blackstone (BX) Director James Breyer bought $1.99M
13,170 shares on the open market. Not a grant or an option exercise.
Avantor (AVTR) Director Gregory Summe bought $1.12M
100,000 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 4 checked quarters beat the typical stock 6 months later.
Opko Health (OPK) CEO & Chairman Frost Phillip Md Et Al bought $213K
150,000 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 9 checked quarters beat the typical stock 6 months later.
Las Vegas Sands (LVS) Chairman & CEO Robert Goldstein sold $53M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Navan (NAVN) CTO Ilan Twig sold $25M
Not marked as a planned 10b5-1 sale. Sold 10% of the shares they held directly. Still holds 8.94M shares.
Fox (FOX) Director Paul Ryan sold $1.14M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 17 more real buys
Show 38 more real sales
13F season
Holdings as of Sep 30, 2025 are due Nov 14
81 funds have filed so far. 74 filed for the quarter before.
Biggest real insider buys, Oct 25–31
Open-market buys by officers and directors, filed in the 7 days up to Oct 31.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.